Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$1.02 - $1.23 $48,852 - $58,910
47,895 New
47,895 $50,000
Q2 2022

Jul 25, 2022

SELL
$0.67 - $1.4 $111,409 - $232,796
-166,283 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$1.23 - $3.31 $32,272 - $86,847
26,238 Added 18.74%
166,283 $204,000
Q4 2021

Jan 28, 2022

BUY
$2.89 - $4.43 $404,730 - $620,399
140,045 New
140,045 $456,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.